Unlike earlier broad-spectrum senolytics that can harm healthy tissue, FOXO4-DRI targets a molecular interaction unique to senescent cells
It belongs to a wider set of peptides moving through longevity and biohacker circles, including BPC-157, Cerebrolysin, Semax, Selank, Dihexa, P21, and the neurotrophic factors BDNF and klotho, whose human cognitive evidence ranges from thin to absent and which I reviewed in detail here
Lastly, L-carnitine can decrease the accumulation of lactate
There was no consensus on the optimal timing of GLP-1 RA add-on therapy after initiating an SGLT2i, nor on the feasibility of initiating both therapies within a 4-week interval (referred to as simultaneous)
Always consult your healthcare provider before combining medications